Ceftazidime/Avibactam, Meropenem/Vaborbactam, or Both? Clinical and Formulary Considerations

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Jason M PogueKeith S Kaye

Abstract

Ceftazidime/avibactam and meropenem/vaborbactam are changing the management of invasive infections due to carbapenem-resistant Enterobacteriaceae (CRE), leading to higher rates of clinical cure, decreased mortality, and decreased rates of acute kidney injury compared with colistin-based regimens. However, these 2 agents are not interchangeable with regard to management of CRE infections, and clinicians need to be aware of their differences. This review focuses on differences in the in vitro activity of these agents as a function of mechanism of carbapenem resistance, the clinical data supporting their superiority over colistin-based therapy, and the differences between agents with regard to propensity for selection of resistance. Furthermore, considerations and recommendations for hospital formularies and antibiotic stewardship programs regarding positioning of these agents are discussed.

References

Apr 14, 2012·The Journal of Antimicrobial Chemotherapy·Laurent PoirelPatrice Nordmann
Aug 24, 2013·The Lancet Infectious Diseases·L Silvia Munoz-PriceJohn P Quinn
Jun 24, 2015·Antimicrobial Agents and Chemotherapy·David M LivermoreNeil Woodford
Jul 1, 2015·Open Forum Infectious Diseases·Haley J MorrillKerry L LaPlante
Jul 22, 2015·Antimicrobial Agents and Chemotherapy·Romney M HumphriesAric Gregson
Dec 18, 2015·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·Barbara AlbigerUNKNOWN European Survey of Carbapenemase-Producing Enterobacteriaceae (EuSCAPE) working group
Sep 15, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ryan K ShieldsM Hong Nguyen
Apr 12, 2017·Antimicrobial Agents and Chemotherapy·Romney M Humphries, Peera Hemarajata
Jun 1, 2017·Antimicrobial Agents and Chemotherapy·Ryan K ShieldsCornelius J Clancy
Aug 30, 2017·Antimicrobial Agents and Chemotherapy·Olga LomovskayaMichael N Dudley
Oct 12, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David van DuinUNKNOWN Antibacterial Resistance Leadership Group
Nov 1, 2017·Antimicrobial Agents and Chemotherapy·Meredith A HackelDaniel F Sahm

❮ Previous
Next ❯

Citations

Nov 18, 2018·Expert Review of Clinical Pharmacology·Daniele Roberto GiacobbeClaudio Viscoli
Feb 21, 2019·Expert Opinion on Pharmacotherapy·Daniele Roberto GiacobbeClaudio Viscoli
Mar 7, 2019·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Pranita D TammaUNKNOWN Antibacterial Resistance Leadership Group
May 29, 2019·Current Opinion in Infectious Diseases·Kaede V Sullivan, Jennifer Dien Bard
Jul 3, 2019·Journal of Clinical Medicine·Nicola PetrosilloGuido Granata
Jan 15, 2020·Current Infectious Disease Reports·Mandee NovalEmily Heil
Dec 18, 2019·Antimicrobial Agents and Chemotherapy·David Aguilera-AlonsoFernando Baquero-Artigao
Dec 25, 2019·Journal of the Pediatric Infectious Diseases Society·Kathleen ChiotosPranita D Tamma
Apr 17, 2020·Expert Review of Anti-infective Therapy·Andrea NovelliMario Tumbarello
Aug 5, 2020·Expert Opinion on Pharmacotherapy·Matteo Bassetti, Daniele Roberto Giacobbe
Jan 21, 2019·Journal of Clinical Pathology·Julian L BurtonUNKNOWN ESGFOR Joint Working Group of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group of
Mar 14, 2019·The Journal of Antimicrobial Chemotherapy·Wesley D KufelBryan T Mogle
Feb 29, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jeffrey R StrichSameer S Kadri
May 2, 2019·Frontiers in Medicine·Matteo BassettiDaniele Roberto Giacobbe
Mar 23, 2019·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Jordi RelloUNKNOWN TOTEM Study Investigators
Jun 20, 2020·Expert Opinion on Pharmacotherapy·Martina SpazianteMario Venditti
Oct 4, 2020·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Rajeev SomanBalaji Veeraraghavan
Nov 4, 2020·Future Microbiology·Matteo BassettiDaniele R Giacobbe
Oct 4, 2020·Current Opinion in Infectious Diseases·Matteo BassettiDaniele Roberto Giacobbe
Nov 17, 2019·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M GiannellaP Viale
Feb 26, 2020·Antimicrobial Agents and Chemotherapy·Renee AckleyChristopher Polk
Jan 7, 2021·Infection and Drug Resistance·Daniele Roberto GiacobbeUNKNOWN ISGRI-SITA (Italian Study Group on Resistant Infections of the Italian Society of Anti-infective Therapy)
Apr 8, 2021·Expert Opinion on Pharmacotherapy·Joseph P LynchGeorge G Zhanel
Oct 14, 2019·Anaesthesia Critical Care & Pain Medicine·Marc LeoneBoris Jung

❮ Previous
Next ❯

Related Concepts

Related Feeds

Beta-lactamase Inhibitors

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Beta-lactamase Inhibitors (ASM)

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Gary WuSpencer Lee
MMWR. Morbidity and Mortality Weekly Report
Centers for Disease Control and Prevention (CDC)
© 2022 Meta ULC. All rights reserved